智通财经APP讯，科笛-B(02487)发布截至2025年12月31日止年度业绩，该集团取得收益人民币3.36亿元(单位下同)，同比增加20.22%;母公司拥有人应占亏损3.4亿元，同比减少21.58%;每股亏损1.03元。
本集团的两款主要产品CU-40102(外用非那雄胺喷雾剂)和CU-10201(外用 4%米诺环素泡沫剂)于2025年10月下旬开始商业化。截至2025年12月31日止年度，两款产品收益合计超过1亿元。
本集团持续优化经营效率。截至2025年12月31日止年度，销售及分销、研发及行政开支同比减少约1.09亿元。年内亏损同比减少约9400万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.